Literature DB >> 9107023

PCR-based diagnosis for Chagas' disease in Bolivian children living in an active transmission area: comparison with conventional serological and parasitological diagnosis.

P Wincker1, J Telleria, M F Bosseno, M A Cardoso, P Marques, N Yaksic, C Aznar, P Liegeard, M Hontebeyrie, F Noireau, C M Morel, S F Breniere.   

Abstract

A large field study has been performed in the Cochabamba region of Bolivia with the aim of comparing the polymerase chain reaction (PCR) with other diagnostic methods for Chagas' disease. The amplification of Trypanosoma cruzi-specific kinetoplast DNA sequences in blood samples was compared with classical serological methods, specific IgM detection and direct parasite visualization for 268 school children in a single village where Chagas' disease transmission is active. Of 113 children positive by classical serology or buffy coat examination, 106 were detected by PCR (sensitivity: 93.8%). We did not observe any significant difference of PCR sensitivity between initial (IgM and/or buffy coat positive) and indeterminate stage (only IgG positive) patients. Among the remaining 155 children unconfirmed as chagasic (who were either only IgM positive, IgG-, IgM-, and buffy coat-negative) only 1 case was PCR positive. This case may be due to DNA contamination, or to a very recent infection not detected otherwise, or to specific immune depression. These results show that PCR is a very sensitive parasitological test for Chagas' disease in active transmission regions. The future follow-up of the possibly infected patients who were only IgM-positive should clarify the interest of PCR and IgM tests in the detection of starting infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9107023     DOI: 10.1017/s0031182096008554

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  10 in total

1.  Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Infectivity for mice of Trypanosoma cruzi I and II strains isolated from different hosts.

Authors:  Marta Bértoli; Miriam Hitomi Andó; Max Jean De Ornelas Toledo; Silvana Marques De Araújo; Mônica Lúcia Gomes
Journal:  Parasitol Res       Date:  2006-01-31       Impact factor: 2.289

Review 3.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy.

Authors:  Lúcia M C Galvão; Egler Chiari; Andréa M Macedo; Alejandro O Luquetti; Simonne A Silva; Ana Lúcia S S Andrade
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 5.  ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.

Authors:  Pedro E A A Brasil; Liane De Castro; Alejandro M Hasslocher-Moreno; Luiz H C Sangenis; José U Braga
Journal:  BMC Infect Dis       Date:  2010-11-25       Impact factor: 3.090

6.  International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.

Authors:  Alejandro G Schijman; Margarita Bisio; Liliana Orellana; Mariela Sued; Tomás Duffy; Ana M Mejia Jaramillo; Carolina Cura; Frederic Auter; Vincent Veron; Yvonne Qvarnstrom; Stijn Deborggraeve; Gisely Hijar; Inés Zulantay; Raúl Horacio Lucero; Elsa Velazquez; Tatiana Tellez; Zunilda Sanchez Leon; Lucia Galvão; Debbie Nolder; María Monje Rumi; José E Levi; Juan D Ramirez; Pilar Zorrilla; María Flores; Maria I Jercic; Gladys Crisante; Néstor Añez; Ana M De Castro; Clara I Gonzalez; Karla Acosta Viana; Pedro Yachelini; Faustino Torrico; Carlos Robello; Patricio Diosque; Omar Triana Chavez; Christine Aznar; Graciela Russomando; Philippe Büscher; Azzedine Assal; Felipe Guhl; Sergio Sosa Estani; Alexandre DaSilva; Constança Britto; Alejandro Luquetti; Janis Ladzins
Journal:  PLoS Negl Trop Dis       Date:  2011-01-11

7.  Human Trypanosoma cruzi infection and seropositivity in dogs, Mexico.

Authors:  Jose G Estrada-Franco; Vandanajay Bhatia; Hector Diaz-Albiter; Laucel Ochoa-Garcia; Alberto Barbabosa; Juan C Vazquez-Chagoyan; Miguel A Martinez-Perez; Carmen Guzman-Bracho; Nisha Garg
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

8.  Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig model.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Jaime Cok; Noelia Angulo; Hermes Escalante; Caryn Bern
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

9.  Trypanosoma cruzi in persons without serologic evidence of disease, Argentina.

Authors:  Oscar A Salomone; Ana L Basquiera; Adela Sembaj; Ana M Aguerri; María E Reyes; Mirtha Omelianuk; Ruth A Fernández; Julio Enders; Atilio Palma; José Moreno Barral; Roberto J Madoery
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

Review 10.  Commercial enzyme-linked immunosorbent assay versuspolymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysis.

Authors:  Pedro Emmanuel Alvarenga Americano do Brasil; Rodolfo Castro; Liane de Castro
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-01       Impact factor: 2.743

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.